![Julian Heslop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julian Heslop
Keine laufenden Positionen mehr
Vermögen: 120 923 $ am 31.07.2026
Profil
Julian Spenser Heslop formerly worked at ViiV Healthcare Ltd., as Chairman, Genelabs Technologies, Inc., as Chief Financial Officer & Executive Director, GSK Plc, as Chief Financial Officer & Executive Director in 2011, Dechra Pharmaceuticals Plc, as Independent Non-Executive Director from 2013 to 2022, The Royal Academy of Arts, as Director, Itaconix Plc, as Independent Non-Executive Director from 2012 to 2018, Glaxo Wellcome Plc, as Financial Controller from 1998 to 2000, Grand Metropolitan Plc, as Controller, and Stoy Hayward Ltd., as Auditor in 1979.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Northern 2 VCT Plc
 Northern 2 VCT Plc Investment ManagersFinance Functions as a private equity fund 0,04 % | 01.11.2025 | 95.000 ( 0,04 % ) | 69 037 $ | 31.07.2026 |
Molten Ventures VCT Plc
 Molten Ventures VCT Plc Investment ManagersFinance Functions as a private equity fund 0,03 % | 01.03.2026 | 102.000 ( 0,03 % ) | 51 886 $ | 31.07.2026 |
Ehemalige bekannte Positionen von Julian Heslop
| Unternehmen | Position | Ende |
|---|---|---|
| DECHRA PHARMACEUTICALS | Direktor/Vorstandsmitglied | 05.09.2022 |
| ITACONIX PLC | Direktor/Vorstandsmitglied | 02.10.2018 |
| GSK PLC | Finanzdirektor/CFO | 31.03.2011 |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Vorsitzender | 01.03.2011 |
Glaxo Wellcome Plc
 Glaxo Wellcome Plc Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets pharmaceuticals | Comptroller/Controller/Auditor | 01.01.2000 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
71
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development | Health Technology |
Glaxo Wellcome Plc
Glaxo Wellcome Plc Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets pharmaceuticals | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Dechra Pharmaceuticals Ltd.
 Dechra Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells veterinary pharmaceuticals | Health Technology |
Grand Metropolitan Plc
 Grand Metropolitan Plc Beverages: AlcoholicConsumer Non-Durables Consumer goods manufacturer | Consumer Non-Durables |
Stoy Hayward Ltd.
 Stoy Hayward Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
The Royal Academy of Arts
 The Royal Academy of Arts Miscellaneous Commercial ServicesCommercial Services Operates an art school | Commercial Services |
Itaconix Plc
 Itaconix Plc Chemicals: Major DiversifiedProcess Industries Develops and manufactures polymer solutions | Process Industries |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
